ID   TDH_PYRHO               Reviewed;         348 AA.
AC   O58389;
DT   28-MAR-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   07-APR-2021, entry version 139.
DE   RecName: Full=L-threonine 3-dehydrogenase {ECO:0000255|HAMAP-Rule:MF_00627};
DE            Short=L-ThrDH {ECO:0000303|PubMed:15902509};
DE            Short=TDH {ECO:0000255|HAMAP-Rule:MF_00627, ECO:0000303|PubMed:16233775};
DE            EC=1.1.1.103 {ECO:0000255|HAMAP-Rule:MF_00627, ECO:0000269|PubMed:15902509, ECO:0000269|PubMed:16233775};
DE   AltName: Full=L-threonine dehydrogenase {ECO:0000303|PubMed:15902509, ECO:0000303|PubMed:16233775};
GN   Name=tdh {ECO:0000255|HAMAP-Rule:MF_00627}; OrderedLocusNames=PH0655;
OS   Pyrococcus horikoshii (strain ATCC 700860 / DSM 12428 / JCM 9974 / NBRC
OS   100139 / OT-3).
OC   Archaea; Euryarchaeota; Thermococci; Thermococcales; Thermococcaceae;
OC   Pyrococcus.
OX   NCBI_TaxID=70601;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3;
RX   PubMed=9679194; DOI=10.1093/dnares/5.2.55;
RA   Kawarabayasi Y., Sawada M., Horikawa H., Haikawa Y., Hino Y., Yamamoto S.,
RA   Sekine M., Baba S., Kosugi H., Hosoyama A., Nagai Y., Sakai M., Ogura K.,
RA   Otsuka R., Nakazawa H., Takamiya M., Ohfuku Y., Funahashi T., Tanaka T.,
RA   Kudoh Y., Yamazaki J., Kushida N., Oguchi A., Aoki K., Yoshizawa T.,
RA   Nakamura Y., Robb F.T., Horikoshi K., Masuchi Y., Shizuya H., Kikuchi H.;
RT   "Complete sequence and gene organization of the genome of a hyper-
RT   thermophilic archaebacterium, Pyrococcus horikoshii OT3.";
RL   DNA Res. 5:55-76(1998).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, COFACTOR, ACTIVITY REGULATION, AND SUBUNIT.
RC   STRAIN=ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3;
RX   PubMed=15902509; DOI=10.1007/s00792-005-0447-2;
RA   Shimizu Y., Sakuraba H., Kawakami R., Goda S., Kawarabayasi Y., Ohshima T.;
RT   "L-Threonine dehydrogenase from the hyperthermophilic archaeon Pyrococcus
RT   horikoshii OT3: gene cloning and enzymatic characterization.";
RL   Extremophiles 9:317-324(2005).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT,
RP   COFACTOR, AND ACTIVITY REGULATION.
RX   PubMed=16233775; DOI=10.1263/jbb.99.175;
RA   Higashi N., Fukada H., Ishikawa K.;
RT   "Kinetic study of thermostable L-threonine dehydrogenase from an archaeon
RT   Pyrococcus horikoshii.";
RL   J. Biosci. Bioeng. 99:175-180(2005).
RN   [4]
RP   REACTION MECHANISM, ACTIVE SITE, AND MUTAGENESIS OF THR-44; GLU-152 AND
RP   ARG-294.
RX   PubMed=18390572; DOI=10.1093/jb/mvn041;
RA   Higashi N., Tanimoto K., Nishioka M., Ishikawa K., Taya M.;
RT   "Investigating a catalytic mechanism of hyperthermophilic L-threonine
RT   dehydrogenase from Pyrococcus horikoshii.";
RL   J. Biochem. 144:77-85(2008).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) IN COMPLEX WITH NAD AND ZINC.
RA   Asada Y., Kunishima N.;
RT   "Crystal structure of PH0655 from Pyrococcus horikoshii OT3.";
RL   Submitted (DEC-2005) to the PDB data bank.
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 2-348 IN COMPLEX WITH NAD AND
RP   ZINC, SUBUNIT, AND MUTAGENESIS OF GLU-199 AND ARG-204.
RX   PubMed=17188300; DOI=10.1016/j.jmb.2006.11.060;
RA   Ishikawa K., Higashi N., Nakamura T., Matsuura T., Nakagawa A.;
RT   "The first crystal structure of L-threonine dehydrogenase.";
RL   J. Mol. Biol. 366:857-867(2007).
CC   -!- FUNCTION: Catalyzes the NAD(+)-dependent oxidation of L-threonine to 2-
CC       amino-3-ketobutyrate (PubMed:16233775, PubMed:15902509). Is much less
CC       efficient when using NADP(+) instead of NAD(+) (PubMed:16233775). To a
CC       lesser extent, also catalyzes the oxidation of L-serine and DL-threo-3-
CC       phenylserine, but not that of L-allo-threonine, D-threonine and D-allo-
CC       threonine and many other L-amino acids (PubMed:15902509).
CC       {ECO:0000269|PubMed:15902509, ECO:0000269|PubMed:16233775}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-threonine + NAD(+) = (2S)-2-amino-3-oxobutanoate + H(+) +
CC         NADH; Xref=Rhea:RHEA:13161, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57926, ChEBI:CHEBI:57945, ChEBI:CHEBI:78948;
CC         EC=1.1.1.103; Evidence={ECO:0000255|HAMAP-Rule:MF_00627,
CC         ECO:0000269|PubMed:15902509, ECO:0000269|PubMed:16233775};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00627,
CC         ECO:0000269|PubMed:15902509, ECO:0000269|PubMed:16233775};
CC       Note=Binds 2 Zn(2+) ions per subunit. Contains one structural ion and
CC       one catalytic ion that seems to be less tightly bound at the site
CC       (PubMed:16233775). Zn(2+) can be replaced by Mn(2+) or Co(2+) to some
CC       extent (PubMed:15902509). {ECO:0000255|HAMAP-Rule:MF_00627,
CC       ECO:0000269|PubMed:15902509, ECO:0000305|PubMed:16233775};
CC   -!- ACTIVITY REGULATION: Is totally inhibited by EDTA in vitro.
CC       {ECO:0000269|PubMed:15902509, ECO:0000269|PubMed:16233775}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.20 mM for L-threonine (at 50 degrees Celsius)
CC         {ECO:0000269|PubMed:15902509};
CC         KM=0.024 mM for NAD(+) (at 50 degrees Celsius)
CC         {ECO:0000269|PubMed:15902509};
CC         KM=0.013 mM for L-threonine (in the presence of NAD(+) as
CC         cosubstrate, at 65 degrees Celsius) {ECO:0000269|PubMed:16233775};
CC         KM=0.010 mM for NAD(+) (at 65 degrees Celsius)
CC         {ECO:0000269|PubMed:16233775};
CC         KM=0.447 mM for L-threonine (in the presence of NAD(+) as
CC         cosubstrate, at 65 degrees Celsius) {ECO:0000269|PubMed:16233775};
CC         KM=0.689 mM for NADP(+) (at 65 degrees Celsius)
CC         {ECO:0000269|PubMed:16233775};
CC         Vmax=1.75 mmol/min/mg enzyme for the NAD(+) oxidation of L-threonine
CC         (at 65 degrees Celsius) {ECO:0000269|PubMed:16233775};
CC         Vmax=1.32 mmol/min/mg enzyme for the NADP(+) oxidation of L-threonine
CC         (at 65 degrees Celsius) {ECO:0000269|PubMed:16233775};
CC       pH dependence:
CC         Optimum pH is around 10. Below and above pH 10, the marked decrease
CC         of activity is observed: the relative activities are 50, 22 and 55%
CC         at pH 9.5, 9.2 and 12, respectively. Is stable over a wide pH range:
CC         upon heating at 50 degrees Celsius for 20 minutes, the enzyme does
CC         not lose activity at pH 4.5-10.0. {ECO:0000269|PubMed:15902509};
CC       Temperature dependence:
CC         Optimum tempreature is 70 degrees Celsius. Extremely thermostable,
CC         the activity is not lost after incubation at 100 degrees Celsius for
CC         20 minutes. {ECO:0000269|PubMed:15902509,
CC         ECO:0000269|PubMed:16233775};
CC   -!- PATHWAY: Amino-acid degradation; L-threonine degradation via oxydo-
CC       reductase pathway; glycine from L-threonine: step 1/2.
CC       {ECO:0000255|HAMAP-Rule:MF_00627, ECO:0000305|PubMed:16233775}.
CC   -!- SUBUNIT: Homodimer (PubMed:16233775). Homotetramer; dimer of dimers
CC       (PubMed:17188300) (PubMed:15902509). {ECO:0000269|PubMed:15902509,
CC       ECO:0000269|PubMed:16233775, ECO:0000269|PubMed:17188300}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00627}.
CC   -!- MISCELLANEOUS: The enzyme shows pro-R stereospecificity for hydrogen
CC       transfer at the C4 position of the nicotinamide moiety of NADH.
CC       {ECO:0000269|PubMed:15902509}.
CC   -!- SIMILARITY: Belongs to the zinc-containing alcohol dehydrogenase
CC       family. {ECO:0000255|HAMAP-Rule:MF_00627}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BA000001; BAA29746.1; -; Genomic_DNA.
DR   PIR; H71110; H71110.
DR   RefSeq; WP_010884751.1; NC_000961.1.
DR   PDB; 2D8A; X-ray; 2.05 A; A=1-348.
DR   PDB; 2DFV; X-ray; 2.05 A; A/B/C=2-348.
DR   PDBsum; 2D8A; -.
DR   PDBsum; 2DFV; -.
DR   SMR; O58389; -.
DR   MINT; O58389; -.
DR   STRING; 70601.3257063; -.
DR   EnsemblBacteria; BAA29746; BAA29746; BAA29746.
DR   GeneID; 1442986; -.
DR   KEGG; pho:PH0655; -.
DR   eggNOG; arCOG01459; Archaea.
DR   OMA; GVFHNTP; -.
DR   OrthoDB; 67758at2157; -.
DR   BioCyc; PHOR70601:G1G39-639-MONOMER; -.
DR   BRENDA; 1.1.1.103; 5244.
DR   SABIO-RK; O58389; -.
DR   UniPathway; UPA00046; UER00505.
DR   EvolutionaryTrace; O58389; -.
DR   Proteomes; UP000000752; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016597; F:amino acid binding; IDA:UniProtKB.
DR   GO; GO:0008743; F:L-threonine 3-dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0070403; F:NAD+ binding; IDA:UniProtKB.
DR   GO; GO:0070401; F:NADP+ binding; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0019518; P:L-threonine catabolic process to glycine; IEA:UniProtKB-UniPathway.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   GO; GO:0006566; P:threonine metabolic process; IDA:UniProtKB.
DR   HAMAP; MF_00627; Thr_dehydrog; 1.
DR   InterPro; IPR013149; ADH_C.
DR   InterPro; IPR013154; ADH_N.
DR   InterPro; IPR002328; ADH_Zn_CS.
DR   InterPro; IPR011032; GroES-like_sf.
DR   InterPro; IPR004627; L-Threonine_3-DHase.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR020843; PKS_ER.
DR   Pfam; PF08240; ADH_N; 1.
DR   Pfam; PF00107; ADH_zinc_N; 1.
DR   SMART; SM00829; PKS_ER; 1.
DR   SUPFAM; SSF50129; SSF50129; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   TIGRFAMs; TIGR00692; tdh; 1.
DR   PROSITE; PS00059; ADH_ZINC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Metal-binding; NAD; NADP; Oxidoreductase; Zinc.
FT   CHAIN           1..348
FT                   /note="L-threonine 3-dehydrogenase"
FT                   /id="PRO_0000160877"
FT   NP_BIND         266..268
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|Ref.5, ECO:0007744|PDB:2D8A"
FT   NP_BIND         291..292
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|Ref.5, ECO:0007744|PDB:2D8A"
FT   ACT_SITE        44
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000305|PubMed:18390572"
FT   ACT_SITE        47
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000305|PubMed:18390572"
FT   METAL           42
FT                   /note="Zinc 1; catalytic"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00627,
FT                   ECO:0000269|Ref.5, ECO:0000305|PubMed:17188300,
FT                   ECO:0000305|PubMed:18390572, ECO:0007744|PDB:2D8A"
FT   METAL           67
FT                   /note="Zinc 1; via tele nitrogen; catalytic"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00627,
FT                   ECO:0000269|Ref.5, ECO:0000305|PubMed:17188300,
FT                   ECO:0000305|PubMed:18390572, ECO:0007744|PDB:2D8A"
FT   METAL           68
FT                   /note="Zinc 1; catalytic"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00627,
FT                   ECO:0000269|Ref.5, ECO:0000305|PubMed:17188300,
FT                   ECO:0000305|PubMed:18390572, ECO:0007744|PDB:2D8A"
FT   METAL           97
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00627,
FT                   ECO:0000269|PubMed:17188300, ECO:0007744|PDB:2DFV"
FT   METAL           100
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00627,
FT                   ECO:0000269|PubMed:17188300, ECO:0007744|PDB:2DFV"
FT   METAL           103
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00627,
FT                   ECO:0000269|PubMed:17188300, ECO:0007744|PDB:2DFV"
FT   METAL           111
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00627,
FT                   ECO:0000269|PubMed:17188300, ECO:0007744|PDB:2DFV"
FT   BINDING         179
FT                   /note="NAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:17188300, ECO:0000269|Ref.5"
FT   BINDING         199
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:17188300, ECO:0000269|Ref.5,
FT                   ECO:0007744|PDB:2D8A, ECO:0007744|PDB:2DFV"
FT   BINDING         204
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:17188300, ECO:0000269|Ref.5,
FT                   ECO:0007744|PDB:2D8A, ECO:0007744|PDB:2DFV"
FT   SITE            152
FT                   /note="Important for catalytic activity for the proton
FT                   relay mechanism but does not participate directly in the
FT                   coordination of zinc atom"
FT                   /evidence="ECO:0000305|PubMed:18390572"
FT   MUTAGEN         44
FT                   /note="T->A: Total loss of enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:18390572"
FT   MUTAGEN         152
FT                   /note="E->A,Q: Almost complete loss of enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:18390572"
FT   MUTAGEN         152
FT                   /note="E->C: 120-fold decrease in catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:18390572"
FT   MUTAGEN         152
FT                   /note="E->D: Shows 3-fold higher turnover rate and reduced
FT                   affinities toward L-threonine and NAD(+), compared to wild-
FT                   type."
FT                   /evidence="ECO:0000269|PubMed:18390572"
FT   MUTAGEN         152
FT                   /note="E->K: Total loss of enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:18390572"
FT   MUTAGEN         199
FT                   /note="E->A: Large decrease in affinity for NAD(+)."
FT                   /evidence="ECO:0000269|PubMed:17188300"
FT   MUTAGEN         204
FT                   /note="R->A: Large decrease in affinity for NAD(+)."
FT                   /evidence="ECO:0000269|PubMed:17188300"
FT   MUTAGEN         294
FT                   /note="R->A: 4000-fold decrease in catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:18390572"
FT   STRAND          4..10
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   STRAND          12..16
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   STRAND          18..23
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   STRAND          31..40
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   HELIX           43..50
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   HELIX           55..58
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   STRAND          61..64
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   STRAND          68..76
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   STRAND          88..91
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   HELIX           101..104
FT                   /evidence="ECO:0007744|PDB:2DFV"
FT   HELIX           108..110
FT                   /evidence="ECO:0007744|PDB:2DFV"
FT   TURN            117..119
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   STRAND          124..132
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   HELIX           133..135
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   STRAND          136..138
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   HELIX           145..148
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   HELIX           151..161
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   STRAND          171..174
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   HELIX           178..189
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   STRAND          194..198
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   HELIX           202..211
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   STRAND          214..217
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   TURN            219..221
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   HELIX           224..231
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   TURN            232..234
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   STRAND          237..242
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   HELIX           247..256
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   STRAND          257..265
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   HELIX           277..280
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   TURN            281..285
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   STRAND          287..290
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   HELIX           297..309
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   TURN            315..317
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   STRAND          318..325
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   HELIX           328..336
FT                   /evidence="ECO:0007744|PDB:2D8A"
FT   STRAND          341..346
FT                   /evidence="ECO:0007744|PDB:2D8A"
SQ   SEQUENCE   348 AA;  37786 MW;  313F368AE83F793E CRC64;
     MSEKMVAIMK TKPGYGAELV EVDVPKPGPG EVLIKVLATS ICGTDLHIYE WNEWAQSRIK
     PPQIMGHEVA GEVVEIGPGV EGIEVGDYVS VETHIVCGKC YACRRGQYHV CQNTKIFGVD
     TDGVFAEYAV VPAQNIWKNP KSIPPEYATL QEPLGNAVDT VLAGPISGKS VLITGAGPLG
     LLGIAVAKAS GAYPVIVSEP SDFRRELAKK VGADYVINPF EEDVVKEVMD ITDGNGVDVF
     LEFSGAPKAL EQGLQAVTPA GRVSLLGLYP GKVTIDFNNL IIFKALTIYG ITGRHLWETW
     YTVSRLLQSG KLNLDPIITH KYKGFDKYEE AFELMRAGKT GKVVFMLK
//
